Christine L. Phillips, MD

Comparison of Fludarabine Versus Bendamustine as a Lymphodepleting Chemotherapy Prior to CAR-T for Large Cell Lymphoma. Ahmed, N; Ali, A; Kim, S; Oloyede, T; Bye, M; Gowda, L; Kamble, RT; Mirza, A-S; Nadiminti, KV; Pophali, PA; Pasquini, MC; Ahmed, S; Ganguly, S; Moskop, A. Transplantation and Cellular Therapy. 2026.

CPX-351 in High-Risk Relapsed Pediatric Acute Leukemia: Real-World Phase 1 Data Establishing the FDA-Approved Dose. Bender, JD; Pommert, L; Backus, LR; Bidwell, A; Blank, C; Breese, EH; Burns, KC; Lane, A; Lee, LH; Mizukawa, B; Ryan, TD; Young, J; Absalon, M; Perentesis, JP. Pediatric Blood and Cancer. 2026; 73(6):e70268.

Emapalumab for Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome Following CD19-Directed CAR-T in Two Patients With B-ALL: Clinical and Biomarker Correlates. Galletta, TJ; Rubinstein, JD; Dandoy, CE; Khoury, R; Faulhaber, A; Phillips, CL; Krupski, C. Pediatric Blood and Cancer. 2026; e70406.

Impact of Extramedullary Disease at Diagnosis on Outcomes Post Allogeneic Hematopoietic Cell Transplant in Children and Young Adults With Acute Myeloid Leukemia: A CIBMTR Report. Rangarajan, HG; Chellapandian, D; Atshan, R; Ahn, KW; Kumar, S; Knight, TE; Leung, W; Ganguly, S; Williams, KM; Shah, NN; Qayed, M; Sharma, A; Broglie, L; Satwani, P. Transplantation and Cellular Therapy. 2026; 32(5):580.e1-580.e18.

Optimizing Haploidentical Donor Selection for Pediatric Hematopoietic Cell Transplant. Liberio, N; Allbee-Johnson, M; Ahn, KW; Moskop, A; Phelan, R; Shaw, BE; Page, KM; Schultz, KR; Phillips, CL; Mehta, PA; Kapoor, N; Doherty, EE; Chavan, RS; Broglie, L. Journal of Clinical Oncology. 2026; 44(11):1003-1015.

Outcomes of Allogeneic Stem Cell Transplantation In the Adolescent and Young Adult Population with Acute Lymphoblastic Leukemia Based on Transplant Center: A Center for International Blood and Marrow Transplant Research (CIBMTR) Study. Guerrettaz, R; Peterson, A; Allbee-Johnson, M; Ahn, KW; Rotz, SJ; Sharma, A; Im, A; Nuechterlein, B; Ahmed, S; Mehta, PA; Phillips, CL; Higgins, R; Broglie, L; Phelan, R. Transplantation and Cellular Therapy. 2026; 32(2):s112.

Biomarker Elevations Associated with Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-like Syndrome after CD19-Directed CAR-T Therapy in Children and Young Adults with Acute B-Lymphoblastic Leukemia. Galletta, TJ; Rubinstein, JD; Krupski, C; Dandoy, CE; Khoury, R; Faulhaber, A; Davies, SM; Phillips, CL. Transplantation and Cellular Therapy. 2026; 32(2):s177.

Validation of a Pre-Infusion Prediction Model for IEC-HS in Children and Young Adults with B-Acute Lymphoblastic Leukemia. Mcnerney, KO; Kwon, S; Naik, S; Fabrizio, VA; Llaurador, G; Sanchez-Pinto, LN; Talleur, AC; Zeng, XL; Baggott, C; Vatsayan, A; Mackall, CL; Laetsch, TW; Gardner, RA; Schultz, L. Transplantation and Cellular Therapy. 2026; 32(2):s580.

Phase II One Arm Multicenter Study of Early Reinfusion of Tisagenlecleucel to Promote Durable B-cell Aplasia in Pediatric and Young Adult Patients with relapsed/refractory CD19-Positive B-cell Acute Lymphoblastic Leukemia (REFUEL) Shahid, S; Mauguen, A; Mcavoy, D; Hosszu, K; Phillips, CL; Schultz, L; Hsieh, EM; Bonifant, CL; Fabrizio, VA; Bisogno, B; Pena, MP; Chapman, N; Boelens, J; Curran, KJ. Transplantation and Cellular Therapy. 2026; 32(2):s593-s594.

Liberalizing hospital proximity requirements for children/young adults with low-burden B-ALL receiving tisagenlecleucel. Appell, LE; Baggott, C; Nguyen, K; Prabhu, S; Pacenta, H; John, S; Fabrizio, VA; Phillips, CL; Rossoff, J; Talano, J-A; Mackall, CL; Laetsch, TW; Mcnerney, K; Schultz, LM. Blood advances. 2026; 10(1):106-110.